[Retracted] Meta-Analysis of the Effectiveness and Safety of Glucocorticoid for the Treatment of IgA Kidney Disease

Table 7

Effect of hormone combined with ACEI drugs on proteinuria in patients with IgA nephropathy.

Glucocorticoid group				Control group			Std. mean difference
Study or subgroup	Mean	Sd	Total	Mean	Sd	Total	Weight	IV, fixed, 95% CI
Kobayashi et al., 1996	0.8	0.5	20	1.5	1.3	26	11.1%	−0.67 [−1.27, −0.07]
Locatelli et al., 2001	0.67	0.5	43	1.48	1.87	43	21.4%	−0.59 [−1.02,−0.15]
Uzu et al., 2003	−1.26	0.56	23	−0.86	0.45	22	10.8%	−0.77 [−1.38, −0.16]
Moriyama et al., 2004	−1.26	0.56	34	−0.86	0.45	31	15.7%	−0.77 [−1.28, −0.27]
Lv et al., 2009	−2.5	0.9	33	−2	0.8	30	15.7%	−0.58 [−1.08,−0.07]
Manno et al., 2009	1.2	2.5	48	1.4	2.3	49	25.3%	−0.08 [−0.48, 0.32]
Total (95% CI)			201			201	100.0%	−0.52 [−0.72, −0.32]

Heterogeneity: Chi’ = 6.63, df = 5 ( = 0.25); F = 25%. Test for overall effect: Z = 5.06 (＜0.00001).